| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/07/2015 | CN104257636A 一种溶菌酶口腔贴膜及其制备方法 An oral film and preparation method lysozyme |
| 01/07/2015 | CN104257601A 酸性超氧化物歧化酶凝胶的制备方法 Preparation of acid gel superoxide dismutase |
| 01/07/2015 | CN104256653A 血癌全营养配方食品 Leukemia full nutritional formula |
| 01/07/2015 | CN104256590A 一种具有清咽润喉功效的组合物 Composition having efficacy Qingyan throat |
| 01/07/2015 | CN104256582A 一种缓解女性更年期各种症状的保健品配方 One kind of relieve menopausal symptoms in women health care recipes |
| 01/07/2015 | CN104256252A 一种分步提取与生物转化偶联制备海带降血压制品的方法 A fractional step extraction and biotransformation products prepared by coupling method kelp lowering blood pressure |
| 01/07/2015 | CN103524628B 重组灵芝免疫调节蛋白与人血清白蛋白融合蛋白及其制备方法与应用 Ganoderma lucidum immunomodulatory protein with recombinant human serum protein and albumin fusion preparation method and application |
| 01/07/2015 | CN103468704B 肽聚糖结合蛋白BjApextrin2及其基因、生产方法和应用 BjApextrin2 peptidoglycan binding protein and its gene, production methods and applications |
| 01/07/2015 | CN103421102B 力墀秀肽及其在制备治疗肿瘤药物中的应用、制备方法 Chi Sau force peptide and its application, preparation method for the preparation of a medicament for the treatment of cancer |
| 01/07/2015 | CN103409384B 一种具有抗病毒活性的对虾蛋白及其应用 Shrimp protein having antiviral activity and its application |
| 01/07/2015 | CN103301444B 重组人胸腺素alpha原蛋白的新用途 New uses of recombinant human thymosin alpha original protein |
| 01/07/2015 | CN103285383B 一种包含菠萝蛋白酶的药物组合物及菠萝蛋白酶肠溶片 The pharmaceutical compositions and pineapple bromelain protease comprising enteric-coated tablets |
| 01/07/2015 | CN103159844B 减低蛇毒神经生长因子免疫毒性使之成为鼠源神经生长因子的药物替代品的方法 Reduce the toxicity of venom nerve growth factor to become immune murine nerve growth factor drug alternatives methods |
| 01/07/2015 | CN103159826B Lys及Lys(Pro-Ala-Lys)修饰的姜黄素衍生物、其合成及在医学中的应用 Lys and Lys (Pro-Ala-Lys) modified curcumin derivatives, synthesis and application in medicine |
| 01/07/2015 | CN103102393B 一种多肽及其在制备抑郁症治疗药物中的应用 A polypeptide and its application in preparing a medicament for the treatment of depression |
| 01/07/2015 | CN103083643B 增加肽、肽模拟物和其他胃肠道转运蛋白底物吸收的方法 Increase peptides, peptidomimetics, and other gastrointestinal transport protein substrates Absorption Method |
| 01/07/2015 | CN103070835B 一种含硼替佐米的冻干组合物及其制备方法 One kind of bortezomib lyophilized composition and preparation method |
| 01/07/2015 | CN103007345B 抗菌生物活性支架及其制备方法 Antibacterial bioactive scaffold and its preparation method |
| 01/07/2015 | CN102988959B Nkg2d的调节 Nkg2d regulation |
| 01/07/2015 | CN102971013B 缀合的凝血因子VIIa Conjugated Factor VIIa |
| 01/07/2015 | CN102961440B 含有人环氧酶及天然阿霉素或类阿霉素的药用组合物、其制备方法及在制备多种药物的应用 Epoxy containing human enzymes natural doxorubicin or doxorubicin class pharmaceutical compositions, methods for their preparation and use in the preparation of a variety of drugs |
| 01/07/2015 | CN102532325B 用羟胺切割法制备天蚕素AD和蛙Buforin II融合抗菌肽及其用途 Prepared with hydroxylamine cutting cecropin AD and frogs Buforin II fusion antimicrobial peptides and their use |
| 01/07/2015 | CN102512659B 一种含有棘白菌素类抗真菌剂的药用组合物及其制备方法和用途 Containing echinocandin antifungal pharmaceutical composition and its preparation method and use |
| 01/07/2015 | CN102482325B 通过抑制微粒的分泌治疗aids或癌症的组合物和方法 By secretion or cancer treatment aids compositions and methods of inhibiting particles |
| 01/07/2015 | CN102458447B 乳铁蛋白和婴幼儿肠的神经元健康及发育 Lactoferrin and infant intestinal neuronal health and development |
| 01/07/2015 | CN102391361B 一种具有抗氧化作用的鹰嘴豆肽及分离纯化方法及用途 A kind of antioxidant peptides chickpeas and separation and purification method and uses |
| 01/07/2015 | CN102170901B 用于治疗胶质细胞瘤(gbm)和其它癌症的肿瘤相关肽组合物及相关抗癌疫苗 Tumor-associated peptide composition and related anti-cancer vaccine for the treatment of glioblastoma (gbm) and other cancers |
| 01/07/2015 | CN102164611B 生长因子metrnl的治疗用途 Therapeutic use of growth factors metrnl |
| 01/07/2015 | CN102083455B Mmp-9的调节剂及其用途 Mmp-9 modulators and uses thereof |
| 01/07/2015 | CN101998860B 用于将糖肽抗生素递送至医学装置表面的组合物和方法 For glycopeptide antibiotic delivered to the medical device surface of the compositions and methods |
| 01/07/2015 | CN101432013B 抗分泌因子对于治疗高眼压的应用 Antisecretory factor for the treatment of elevated intraocular pressure applications |
| 01/06/2015 | US8927699 Methods for obtaining thermostable enzymes, DNA polymerase I variants from Thermus aquaticus having new catalytic activities, methods for obtaining the same, and applications to the same |
| 01/06/2015 | US8927694 Human serum albumin linkers and conjugates thereof |
| 01/06/2015 | US8927693 Fibronectin based scaffold domain proteins that bind IL-23 |
| 01/06/2015 | US8927690 Process for purifying cyclolipopeptide compounds or the salts thereof |
| 01/06/2015 | US8927689 Peptide nanostructures and methods of generating and using the same |
| 01/06/2015 | US8927688 PAR4 agonist peptides |
| 01/06/2015 | US8927503 Modulations of protease activated receptors |
| 01/06/2015 | US8927502 Embedded chimeric peptide nucleic acids and uses thereof |
| 01/06/2015 | US8927501 αvβ6 peptide ligands and their uses |
| 01/06/2015 | US8927500 Peptidomimetic macrocycles |
| 01/06/2015 | US8927498 Compositions and methods useful in enhancement of memory |
| 01/06/2015 | US8927496 Process for the synchronization of ovulation for timed breeding without heat detection |
| 01/06/2015 | US8927495 Use of GnRH and analogs thereof for the prevention and treatment of pet ferret adrenocortical hyperplasia |
| 01/06/2015 | US8927493 Promoter for regeneration of tendon-bone junction tissue or ligament-bone junction tissue |
| 01/06/2015 | US8927492 Fibroblast growth factor 21 proteins |
| 01/06/2015 | US8927491 Methods for forming compositions for treating joints comprising bone morphogenetic protein and hyaluronic acid |
| 01/06/2015 | US8927489 Sustained release preparation of pro-insulin C-peptide |
| 01/06/2015 | US8927488 Pegylated C-peptide |
| 01/06/2015 | US8927487 Antimicrobial cationic peptides and formulations thereof |
| 01/06/2015 | US8927486 Compounds |
| 01/06/2015 | US8927485 Site-specific modification of proteins through chemical modification enabling protein conjugates, protein dimer formation, and stapled peptides |
| 01/06/2015 | US8927484 Antiviral compounds |
| 01/06/2015 | US8927483 Neuregulins for prevention and treatment of damage from acute assault on vascular and neuronal tissue and as regulators of neuronal stem cell migration |
| 01/06/2015 | US8927292 Methods of evaluating peptide mixtures |
| 01/06/2015 | US8927281 Method for expanding hematopoietic stem cells |
| 01/06/2015 | US8927274 Populations of pancreatic progenitor cells and methods of isolating and using same |
| 01/06/2015 | US8927253 Administration of enzyme and prebiotic combinations that enhance probiotic growth and efficacy |
| 01/06/2015 | US8927251 Targeting of herpes simplex virus to specific receptors |
| 01/06/2015 | US8927249 Extended soluble PH20 polypeptides and uses thereof |
| 01/06/2015 | US8927242 Treatment and prophylaxis for obsessive compulsive disorder |
| 01/06/2015 | US8927232 Fusion protein capable of binding VEGF-A and TNF-alpha |
| 01/06/2015 | US8927206 Virus causing respiratory tract illness in susceptible mammals |
| 01/06/2015 | US8927205 Recombinant polypeptides of the members of the TNF ligand family and use thereof |
| 01/06/2015 | US8927022 Granules of porous biocompatible materials |
| 01/06/2015 | US8927019 Methods and compositions for treating recurrent cancer |
| 01/06/2015 | US8927016 Producing a sustained-release preparation |
| 01/06/2015 | US8927015 Formulations for delivering insulin |
| 01/06/2015 | US8927007 Formulations for treatment with glucosinolates |
| 01/06/2015 | US8927005 Liquid formulations for treatment of diseases or conditions |
| 01/06/2015 | US8926990 Treatment and diagnosis of inflammatory disorders and HIV |
| 01/06/2015 | US8926989 Compositions and methods for screening for Lyme disease |
| 01/06/2015 | US8926974 Methods of treating a tauopathy |
| 01/06/2015 | US8926973 Reducing the immunogenicity of fusion proteins |
| 01/06/2015 | US8926972 Anti-angiogenesis fusion proteins |
| 01/06/2015 | US8926970 Rspondin antibodies as inhibiting factors of angiogenesis and vaculogenesis |
| 01/06/2015 | US8926967 Intraventricular enzyme delivery for lysosomal storage diseases |
| 01/06/2015 | US8926966 Cloned glutamic acid decarboxylase |
| 01/06/2015 | US8926965 Nucleic acid encoding superoxide dismutase variants and methods of use thereof |
| 01/06/2015 | US8926963 Compositions and soft tissue replacement methods |
| 01/06/2015 | US8926958 Prevention and treatment of vascular disease with recombinant adeno-associated virus vectors encoding apolipoprotein A-I and apolipoprotein A-I milano |
| 01/06/2015 | US8926949 Composition for oral health treatment and related methods of use |
| 01/06/2015 | US8926946 Peptides for transport of therapeutics and their carriers in mouse models and humans |
| 01/06/2015 | US8926710 Osteoinductive bone graft injectable cement |
| 01/06/2015 | US8926595 Devices, formulations, and methods for delivery of multiple beneficial agents |
| 01/06/2015 | CA2831938C Methods and uses of semaphorin 3e polypeptides and polynucleotides involving an airway inflammatory disease |
| 01/06/2015 | CA2789123C Insulinotropic peptide derivative wherein its n-terminal amino acid is modified |
| 01/06/2015 | CA2642847C Dissolution aids for oral peptide delivery comprising a biguanide |
| 01/06/2015 | CA2631039C Multimeric complexes of antigens and an adjuvant |
| 01/06/2015 | CA2607697C Treating and evaluating inflammatory disorders |
| 01/06/2015 | CA2574907C Physiologically-active composition based on collagen |
| 01/06/2015 | CA2562035C Treatment of depressive disorders |
| 01/06/2015 | CA2546843C Compounds and methods for increasing neurogenesis |
| 01/06/2015 | CA2542913C Oligopeptides as coating material for medical products |
| 01/06/2015 | CA2537238C Delivery of therapeutic compounds to the brain and other tissues |
| 01/06/2015 | CA2477195C Deleted sequence in m. tuberculosis, method for detecting mycobacteria using these sequences and vaccines |
| 01/01/2015 | US20150005342 Hepatitis C Virus Inhibitors |
| 01/01/2015 | US20150005327 Use of RNAI Inhibiting PARP Activity for the Manufacture of a Medicament for the Treatment of Cancer |
| 01/01/2015 | US20150005272 Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor |
| 01/01/2015 | US20150005241 Linaclotide compositions |